US 12,251,445 B2
Gamma-hydroxybutyrate delivering compounds and processes for making and using them
Sanjib Bera, Blacksburg, VA (US); Sven Guenther, Coralville, IA (US); Adam Smith, Orlando, FL (US); and Travis Mickle, Kissimmee, FL (US)
Assigned to Zevra Therapeutics, Inc.
Filed by Zevra Therapeutics, Inc., Celebration, FL (US)
Filed on Apr. 19, 2023, as Appl. No. 18/303,226.
Claims priority of provisional application 63/333,391, filed on Apr. 21, 2022.
Prior Publication US 2023/0382880 A1, Nov. 30, 2023
Int. Cl. A61K 47/54 (2017.01); A61K 45/06 (2006.01); A61P 25/20 (2006.01); C07C 69/14 (2006.01); C07C 69/88 (2006.01); C07C 69/96 (2006.01); C07C 233/47 (2006.01); C07C 271/64 (2006.01); C07C 271/66 (2006.01); C07C 301/00 (2006.01); C07C 307/02 (2006.01); C07C 307/06 (2006.01); C07C 333/10 (2006.01); C07D 307/20 (2006.01); C07D 407/12 (2006.01); C07F 9/09 (2006.01); C07F 9/24 (2006.01); A61K 9/00 (2006.01)
CPC A61K 47/542 (2017.08) [A61K 45/06 (2013.01); A61P 25/20 (2018.01); C07C 69/14 (2013.01); C07C 69/88 (2013.01); C07C 69/96 (2013.01); C07C 233/47 (2013.01); C07C 271/64 (2013.01); C07C 271/66 (2013.01); C07C 301/00 (2013.01); C07C 307/02 (2013.01); C07C 307/06 (2013.01); C07C 333/10 (2013.01); C07D 307/20 (2013.01); C07D 407/12 (2013.01); C07F 9/09 (2013.01); C07F 9/2404 (2013.01); C07F 9/2458 (2013.01); A61K 9/0048 (2013.01)] 19 Claims
 
1. A compound is selected from the group consisting of

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.